WHO Recommends a Clinical Trial of Ebola Vaccine Against Bundibugyo Virus
11 Articles
11 Articles
The World Health Organization says the Ebola epidemic death toll continues to rise, as does the number of infections. “The Ebola situation has not been good for three months now. We have nearly 2,000 deaths and 4,000 people infected,” said Mohamed Yakub Janabi, WHO Regional Director for Africa, [...]
The World Health Organization (WHO) says that the Ebola epidemic continues to grow, as do the number of infections. "The situation concerning Ebola, for three months now, is not good. We have nearly 2,000 people dead. And we have 4,000 people affected," says Mohamed Yakub Janabi, WHO Regional Director for Africa, at a press conference in Bunia, eastern Democratic Republic of the Congo, epicentre of the epidemic.
WHO recommends a clinical trial of Ebola vaccine against Bundibugyo virus
The recommendation followed preliminary animal study data suggesting that the vaccine may provide some cross-protection against the disease, particularly in reducing deaths. The post WHO recommends a clinical trial of Ebola vaccine against Bundibugyo virus appeared first on Premium Times Nigeria.
A first volunteer received an experimental vaccine designed against the Ebola virus, variant Bundibugyo. This step opens the first human clinical trial specifically targeting this species of the virus. The program responds to an ongoing outbreak in the Democratic Republic of...
Geneva – In light of the Ebola epidemic in the Democratic Republic of Congo (DRC), vaccine experts from the World Health Organization (WHO) have urged clinical trials of a vaccine approved against a different Ebola variant. The Ervebo vaccine has proven effective and, according to initial results, could also be effective against the strain in the DRC...
Coverage Details
Bias Distribution
- 75% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
